Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
W. H. Daugherty & Son Refining Company was a historically significant manufacturer of high-purity white mineral oils and petrolatums, primarily serving the pharmaceutical and personal care industries. Based in Petrolia, Pennsylvania, the company pioneered the production of USP-grade medicinal oils under the Penn-Drake brand, which were widely used as excipients in ointments, creams, and laxatives. The company's refining operations were eventually acquired by L. Sonneborn Sons in 1924, becoming a foundational part of the Sonneborn brand. Today, the legacy of W. H. Daugherty continues through the Petrolia facility, which remains a major global production site for pharmaceutical-grade white oils under the ownership of HF Sinclair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on W. H. Daugherty.